Literature DB >> 4728677

Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase.

R C Hughes, P D Palmer, B H Sanford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4728677

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Lymphocytes express Ia antigens of foreign haplotype following treatment with neuraminidase.

Authors:  C R Parish; T J Higgins; I F McKenzie
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.

Authors:  H H Sedlacek; G Hagmayer; F R Seiler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Variants of hamster fibroblasts resistant to Ricinus communis toxin (ricin).

Authors:  A Meager; A Ungkitchanukit; R C Hughes
Journal:  Biochem J       Date:  1976-01-15       Impact factor: 3.857

4.  Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.

Authors:  Patricia S Cho; Diana P Lo; Krzysztof J Wikiel; Haley C Rowland; Rebecca C Coburn; Isabel M McMorrow; Jennifer G Goodrich; J Scott Arn; Robert A Billiter; Stuart L Houser; Akira Shimizu; Yong-Guang Yang; David H Sachs; Christene A Huang
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

5.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

7.  Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.